 Lymphokines
"Lymphokines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity.
| Descriptor ID |
D008222
|
| MeSH Number(s) |
D12.644.276.374.480 D12.776.467.374.480 D23.529.374.480
|
| Concept/Terms |
Lymphokines- Lymphokines
- Lymphocyte Mediators
- Mediators, Lymphocyte
|
Below are MeSH descriptors whose meaning is more general than "Lymphokines".
Below are MeSH descriptors whose meaning is more specific than "Lymphokines".
This graph shows the total number of publications written about "Lymphokines" by people in this website by year, and whether "Lymphokines" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 0 | 1 | 1 | | 1981 | 1 | 1 | 2 | | 1982 | 1 | 0 | 1 | | 1983 | 3 | 0 | 3 | | 1984 | 7 | 0 | 7 | | 1985 | 1 | 1 | 2 | | 1986 | 4 | 1 | 5 | | 1987 | 2 | 3 | 5 | | 1988 | 2 | 3 | 5 | | 1989 | 0 | 5 | 5 | | 1990 | 0 | 1 | 1 | | 1991 | 1 | 3 | 4 | | 1992 | 2 | 1 | 3 | | 1993 | 1 | 1 | 2 | | 1994 | 2 | 1 | 3 | | 1995 | 4 | 3 | 7 | | 1996 | 3 | 1 | 4 | | 1997 | 0 | 2 | 2 | | 1998 | 1 | 1 | 2 | | 1999 | 5 | 0 | 5 | | 2000 | 3 | 3 | 6 | | 2001 | 5 | 2 | 7 | | 2002 | 4 | 6 | 10 | | 2003 | 2 | 1 | 3 | | 2004 | 1 | 0 | 1 | | 2007 | 0 | 1 | 1 | | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Lymphokines" by people in Profiles.
-
Armstrong AJ, Nixon AB, Carmack A, Yang Q, Eisen T, Stadler WM, Jones RJ, Garcia JA, Vaishampayan UN, Picus J, Hawkins RE, Hainsworth JD, Kollmannsberger CK, Logan TF, Puzanov I, Pickering LM, Ryan CW, Protheroe A, George DJ, Halabi S. Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell Carcinoma. Clin Cancer Res. 2021 06 15; 27(12):3317-3328.
-
Zhou J, Huang Y, Huang RS, Wang F, Xu L, Le Y, Yang X, Xu W, Huang X, Lian J, Duan S. A case-control study provides evidence of association for a common SNP rs974819 in PDGFD to coronary heart disease and suggests a sex-dependent effect. Thromb Res. 2012 Oct; 130(4):602-6.
-
Ranjbaran H, Sokol SI, Gallo A, Eid RE, Iakimov AO, D'Alessio A, Kapoor JR, Akhtar S, Howes CJ, Aslan M, Pfau S, Pober JS, Tellides G. An inflammatory pathway of IFN-gamma production in coronary atherosclerosis. J Immunol. 2007 Jan 01; 178(1):592-604.
-
Ustach CV, Taube ME, Hurst NJ, Bhagat S, Bonfil RD, Cher ML, Schuger L, Kim HR. A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progression. Cancer Res. 2004 Mar 01; 64(5):1722-9.
-
Seipelt RG, Backer CL, Mavroudis C, Stellmach V, Seipelt IM, Cornwell M, Hernandez J, Crawford SE. Topical VEGF enhances healing of thoracic aortic anastomosis for coarctation in a rabbit model. Circulation. 2003 Sep 09; 108 Suppl 1:II150-4.
-
Huang J, Frischer JS, Serur A, Kadenhe A, Yokoi A, McCrudden KW, New T, O'Toole K, Zabski S, Rudge JS, Holash J, Yancopoulos GD, Yamashiro DJ, Kandel JJ. Regression of established tumors and metastases by potent vascular endothelial growth factor blockade. Proc Natl Acad Sci U S A. 2003 Jun 24; 100(13):7785-90.
-
Kohli M, Kaushal V, Spencer HJ, Mehta P. Prospective study of circulating angiogenic markers in prostate-specific antigen (PSA)-stable and PSA-progressive hormone-sensitive advanced prostate cancer. Urology. 2003 Apr; 61(4):765-9.
-
Li B, Xu W, Luo C, Gozal D, Liu R. VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death. Brain Res Mol Brain Res. 2003 Mar 17; 111(1-2):155-64.
-
McCrudden KW, Hopkins B, Frischer J, Novikov A, Huang J, Kadenhe A, New T, Yokoi A, Yamashiro DJ, Kandel JJ, Middlesworth W. Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis. J Pediatr Surg. 2003 Mar; 38(3):308-14; discussion 308-14.
-
Jones KL, Krous HF, Nadeau J, Blackbourne B, Zielke HR, Gozal D. Vascular endothelial growth factor in the cerebrospinal fluid of infants who died of sudden infant death syndrome: evidence for antecedent hypoxia. Pediatrics. 2003 Feb; 111(2):358-63.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|